Correlation Between Karuna Therapeutics and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Karuna Therapeutics and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karuna Therapeutics and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karuna Therapeutics and ZyVersa Therapeutics, you can compare the effects of market volatilities on Karuna Therapeutics and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karuna Therapeutics with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karuna Therapeutics and ZyVersa Therapeutics.
Diversification Opportunities for Karuna Therapeutics and ZyVersa Therapeutics
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Karuna and ZyVersa is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Karuna Therapeutics and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Karuna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karuna Therapeutics are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Karuna Therapeutics i.e., Karuna Therapeutics and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Karuna Therapeutics and ZyVersa Therapeutics
Given the investment horizon of 90 days Karuna Therapeutics is expected to generate 0.24 times more return on investment than ZyVersa Therapeutics. However, Karuna Therapeutics is 4.23 times less risky than ZyVersa Therapeutics. It trades about 0.0 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 21,092 in Karuna Therapeutics on September 3, 2024 and sell it today you would lose (781.00) from holding Karuna Therapeutics or give up 3.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 30.91% |
| Values | Daily Returns |
Karuna Therapeutics vs. ZyVersa Therapeutics
Performance |
| Timeline |
| Karuna Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| ZyVersa Therapeutics |
Karuna Therapeutics and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Karuna Therapeutics and ZyVersa Therapeutics
The main advantage of trading using opposite Karuna Therapeutics and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karuna Therapeutics position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| Karuna Therapeutics vs. Blueprint Medicines Corp | Karuna Therapeutics vs. Amylyx Pharmaceuticals | Karuna Therapeutics vs. Day One Biopharmaceuticals | Karuna Therapeutics vs. X4 Pharmaceuticals |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |